Jones Lang LaSalle, Inc. (JLL)
Jones Lang LaSalle, Inc. (JLL) is a global commercial real estate services firm that specializes in property management, leasing, sales, and investment management. Founded in 1783, JLL provides expertise in real estate strategy, analytics, and project management, serving clients across various sectors including office, retail, industrial, and residential properties worldwide.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 13, 2019 | $0.43 | 2019-11-14 | 2019-11-15 |
| June 14, 2019 | $0.43 | 2019-05-16 | 2019-05-17 |
| December 14, 2018 | $0.41 | 2018-11-15 | 2018-11-16 |
| June 15, 2018 | $0.41 | 2018-05-17 | 2018-05-18 |
| December 15, 2017 | $0.37 | 2017-11-15 | 2017-11-16 |
Dividends Summary
- Jones Lang LaSalle, Inc. has issued 29 dividend payments over the past 14 years
- The most recent dividend was paid 2108 days ago, on December 13, 2019
- The highest dividend payed out to investors during this period was $0.5 per share
- The average dividend paid during this period was $0.28 per share.
Company News
Goldman Sachs is bullish on the commercial real estate services sector, citing a gradual recovery in property values, financing conditions, and origination volumes. The investment bank recommends CBRE Group, Newmark Group, and Jones Lang LaSalle as top picks for 2025.
CBRE Group, Inc. is set to announce its second-quarter 2024 earnings on July 25. The company is expected to benefit from its diversified business model, technology investments, and cost reduction initiatives, though persistent macroeconomic uncertainties may impact commercial real estate transactions.
The new hot spot in commercial real estate is workforce housing for computers that power artificial intelligence.
The Fund generated a return of +23.27% (after fees) versus +10.85% (before fees) for the Fund’s most relevant benchmark. Click here to read the full fund letter.
Commercial real estate has come under immense pressure in the high interest rate environment, creating an opportunity for patient investors.
